Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in UNITED STATES :
sales of $48.67 billion
of which 46%
Merck & Co. , Inc.
of which 89%
was Merck Pharmaceutical), and
of which 78%
was Innovative Medicines).
During the year ended December of 2019, sales at
Pfizer Inc. were $51.75 billion.
decrease of 3.5%
versus 2018, when the company's sales were $53.65 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Pfizer Inc. had sales
of $49.61 billion.